In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer

Hepatocellular carcinoma (HCC) is an aggressive liver cancer with limited effective treatment options. In this study, we selected TLR agonists imiquimod (IMQ), gardiquimod (GARD), GS-9620 and DSR 6434, and a small molecule checkpoint inhibitor, BMS-202, for characterization of drug loading and relea...

Descripción completa

Detalles Bibliográficos
Autores principales: Negussie, Ayele H., Mikhail, Andrew S., Owen, Joshua W., Hong, Natalie, Carlson, Camella J., Tang, Yiqing, Carrow, Kendal Paige, Mauda-Havakuk, Michal, Lewis, Andrew L., Karanian, John W., Pritchard, William F., Wood, Bradford J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763333/
https://www.ncbi.nlm.nih.gov/pubmed/36535979
http://dx.doi.org/10.1038/s41598-022-26094-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763333/
https://www.ncbi.nlm.nih.gov/pubmed/36535979
http://dx.doi.org/10.1038/s41598-022-26094-1

Ejemplares similares